1. Home
  2. GROW vs INKT Comparison

GROW vs INKT Comparison

Compare GROW & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • INKT
  • Stock Information
  • Founded
  • GROW 1968
  • INKT 2017
  • Country
  • GROW United States
  • INKT United States
  • Employees
  • GROW N/A
  • INKT N/A
  • Industry
  • GROW Investment Managers
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • GROW Finance
  • INKT Health Care
  • Exchange
  • GROW Nasdaq
  • INKT Nasdaq
  • Market Cap
  • GROW 31.8M
  • INKT 28.8M
  • IPO Year
  • GROW N/A
  • INKT 2021
  • Fundamental
  • Price
  • GROW $2.43
  • INKT $62.86
  • Analyst Decision
  • GROW
  • INKT Strong Buy
  • Analyst Count
  • GROW 0
  • INKT 2
  • Target Price
  • GROW N/A
  • INKT $37.50
  • AVG Volume (30 Days)
  • GROW 44.8K
  • INKT 2.4M
  • Earning Date
  • GROW 09-09-2025
  • INKT 08-12-2025
  • Dividend Yield
  • GROW 3.68%
  • INKT N/A
  • EPS Growth
  • GROW N/A
  • INKT N/A
  • EPS
  • GROW 0.01
  • INKT N/A
  • Revenue
  • GROW $8,932,000.00
  • INKT N/A
  • Revenue This Year
  • GROW N/A
  • INKT N/A
  • Revenue Next Year
  • GROW N/A
  • INKT N/A
  • P/E Ratio
  • GROW $229.56
  • INKT N/A
  • Revenue Growth
  • GROW N/A
  • INKT N/A
  • 52 Week Low
  • GROW $2.02
  • INKT $4.56
  • 52 Week High
  • GROW $2.73
  • INKT $76.00
  • Technical
  • Relative Strength Index (RSI)
  • GROW 52.72
  • INKT 57.39
  • Support Level
  • GROW $2.38
  • INKT $6.80
  • Resistance Level
  • GROW $2.49
  • INKT $7.88
  • Average True Range (ATR)
  • GROW 0.09
  • INKT 0.40
  • MACD
  • GROW -0.01
  • INKT 0.02
  • Stochastic Oscillator
  • GROW 24.24
  • INKT 58.86

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: